Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia

By Daskalopoulou Stella S.   Mikhailidis Dimitri P.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2037-2039

Informa Healthcare

Access to resources Recommend Favorite

Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe–statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia

By Assmann Gerd   Kannenberg Frank   Ramey Dena R.   Musliner Thomas A.   Gutkin Stephen W.   Veltri Enrico P.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 249-259

Informa Healthcare

Access to resources Recommend Favorite

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients

By Catapano Alberico L.   Davidson Michael H.   Ballantyne Christie M.   Brady William E.   Gazzara Russell A.   Tomassini Joanne E.   Tershakovec Andrew M.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2041-2053

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of rosuvastatin versus ezetimibe/simvastatin in managing dyslipidemic patients in Mexico

By Briseño Germán Gómez   Mino-León Dolores  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1075-1081

Informa Healthcare

Access to resources Recommend Favorite

Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia

By Bays Harold   Sapre Aditi   Taggart William   Liu Ji   Capece Rachel   Tershakovec Andrew  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2953-2966

Informa Healthcare

Access to resources Recommend Favorite